ArticleJMIR formative research2026
Validation of a Low-Burden, Once-Daily Obsessive-Compulsive Disorder Measure Over 70 Days: Ecological Momentary Assessment Study.
Article in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ecological momentary assessments (EMAs) are an increasingly popular tool used to measure real-time symptom burden within mental health care, including for obsessive-compulsive disorder (OCD). However, prior studies in the literature have been limited by brief assessment periods, high participant burden, and heterogeneity in both sampling and symptom assessment methodologies. Objective: This study aimed to validate a 12-item EMA questionnaire of OCD symptoms by evaluating its psychometric properties over an extended monitoring period. Methods: Adults with OCD (22/41, 53.7%) and demographically matched healthy controls (19/41, 46.3%) completed up to 70 daily smartphone-delivered EMA surveys assessing the frequency and emotional impact of obsessions and compulsions. Participants with OCD also underwent clinician-administered Yale-Brown Obsessive-Compulsive Scale evaluations at weeks 0, 2, and 10. Results: Our scale demonstrated high internal consistency (Cronbach α=0.96) and convergent validity, with significant correlation with Yale-Brown Obsessive-Compulsive Scale scores at week 2 (ρ=0.59; P=.004) and week 10 (ρ=0.53; P=.01). Participant retention (89.1%) and questionnaire completion rate (89%) were also higher than those seen in the literature (75.2% and 74.2%, respectively). Conclusions: Overall, we provide initial psychometric support for the use of a low-burden EMA tool to capture day-to-day OCD symptom fluctuations over extended periods. Such tools may enhance longitudinal symptom monitoring, improve treatment response tracking, and address limitations inherent in traditional retrospective assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.